Security key
75383L102
Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)
CUSIP: 75383L102
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 47,779,015
- Total 13F shares
- 49,276,697
- Share change
- +10,776,624
- Total reported value
- $1,463,478,389
- Put/Call ratio
- 72%
- Price per share
- $29.70
- Number of holders
- 123
- Value change
- +$335,895,056
- Number of buys
- 86
- Number of sells
- 29
Report period
Q3 2025
Institutions
123
Top holders
10
RAPP full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Rapport Therapeutics, Inc. SEC filings
Rapport Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75383L102
Recent filing periods:
Top shareholders of RAPP - Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Third Rock Ventures V, L.P. |
13D/G
|
— |
20%
|
7,135,233
|
$81,198,952 | $0 | 31 Dec 2024 | |
| JOHNSON & JOHNSON |
13D/G
13F
|
Company |
4.9%
|
1,784,517
|
$53,000,690 | $0 | 30 Sep 2025 | |
| Sofinnova Venture Partners XI, L.P. |
13D/G
|
Dr. James I. Healy ("Healy") |
4.2%
|
1,947,579
|
$29,155,258 | $0 | 11 Sep 2025 | |
| TRV GP V, LLC |
13F
|
Company |
15%
|
7,135,233
|
$81,127,599 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
11%
|
5,474,633
|
$62,246,578 | — | 30 Jun 2025 | |
| ARCH Venture Management, LLC |
13F
|
Company |
7.8%
|
3,728,738
|
$42,433,038 | — | 30 Jun 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
6.2%
|
2,940,921
|
$33,438,272 | — | 30 Jun 2025 | |
| Capital International Investors |
13F
|
Company |
5.4%
|
2,602,529
|
$29,590,755 | — | 30 Jun 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
4.2%
|
1,995,594
|
$22,689,904 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.2%
|
1,525,519
|
$17,346,000 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.6%
|
1,235,035
|
$14,042,348 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
2.6%
|
1,219,201
|
$13,862,316 | — | 30 Jun 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
2.4%
|
1,154,688
|
$13,128,803 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
1,107,491
|
$12,592,172 | — | 30 Jun 2025 | |
| TRV GP VI, LLC |
13F
|
Company |
2%
|
969,218
|
$11,020,009 | — | 30 Jun 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.3%
|
613,819
|
$6,980,000 | — | 30 Jun 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.2%
|
550,090
|
$6,254,523 | — | 30 Jun 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.79%
|
378,469
|
$4,303,193 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
333,159
|
$3,788,559 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.63%
|
298,708
|
$3,396,310 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.57%
|
273,507
|
$3,109,775 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.51%
|
243,880
|
$2,772,916 | — | 30 Jun 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.44%
|
208,910
|
$2,375,307 | — | 30 Jun 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.42%
|
199,643
|
$2,269,941 | — | 30 Jun 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.41%
|
196,870
|
$2,238,412 | — | 30 Jun 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.41%
|
194,200
|
$2,208,054 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.39%
|
185,028
|
$2,103,768 | — | 30 Jun 2025 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.38%
|
179,860
|
$2,045,008 | — | 30 Jun 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.27%
|
131,340
|
$1,493,336 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.24%
|
116,273
|
$1,322,024 | — | 30 Jun 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.21%
|
100,424
|
$1,141,821 | — | 30 Jun 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
0.21%
|
98,237
|
$1,116,955 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.2%
|
93,497
|
$1,063,061 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.15%
|
71,108
|
$808,497 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.15%
|
69,463
|
$789,793 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.08%
|
40,104
|
$455,982 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
24,949
|
$283,664 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
24,884
|
$282,931 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.05%
|
21,873
|
$248,696 | — | 30 Jun 2025 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.04%
|
20,000
|
$227,400 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.04%
|
19,743
|
$224,478 | — | 30 Jun 2025 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.04%
|
19,712
|
$224,125 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.04%
|
16,972
|
$192,971 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
15,600
|
$177,372 | — | 30 Jun 2025 | |
| SummitTX Capital, L.P. |
13F
|
Company |
0.03%
|
12,594
|
$143,194 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
12,127
|
$137,884 | — | 30 Jun 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.02%
|
11,462
|
$130,323 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
11,267
|
$128,106 | — | 30 Jun 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.02%
|
11,230
|
$127,685 | — | 30 Jun 2025 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.02%
|
10,863
|
$123,513 | — | 30 Jun 2025 |
Institutional Holders of Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP) as of Q3 2025
As of 30 Sep 2025,
Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP) was held by
123 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,276,697 shares.
The largest 10 holders included
TRV GP V, LLC, FMR LLC, ARCH Venture Management, LLC, Capital International Investors, Cormorant Asset Management, LP, GOLDMAN SACHS GROUP INC, Sofinnova Investments, Inc., JOHNSON & JOHNSON, VANGUARD GROUP INC, and BlackRock, Inc..
This page lists
124
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
81
Q3 2025 holders
123
Holder diff
42
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.